Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

U.S. futures rise with eyes on Fed meeting; Dow Jones up 0.28%

Published 04/29/2014, 06:44 AM
Updated 04/29/2014, 06:44 AM
U.S. futures point to higher open ahead of Fed meeting

Investing.com - U.S. stock futures pointed to a higher open on Tuesday, as Monday's strong U.S. home sales data continued to fuel optimism over the strength of the U.S. economic recovery and as markets turned to the Federal Reserve's upcoming policy meeting.

Ahead of the open, the Dow 30 futures pointed to a 0.28% rise, S&P 500 futures signaled a 0.33% gain, while the Nasdaq 100 futures indicated a 0.50% climb.

On Monday, data showed that U.S. pending home sales rose for the first time in nine months in March, indicating that the housing market is picking up.

The National Association of Realtors reported that pending home sales jumped 3.4% last month, easily surpassing expectations for a 1% gain. Pending home sales for February were revised to a 0.5% drop from a previously reported decline of 0.8%.

The telecom sector was slated to be in focus, after mobile-phone carrier AT&T (NYSE:T) said it is preparing to introduce 4G LTE wireless Internet access to commercial flights. Shares were steady, up 0.06%, in after-hour trade.

Internet-related stocks were aslo expected to be active, following news LinkedIn (NYSE:LNKD) Chief Executive Officer Jeff Weiner’s total compensation rose more than 40-fold to $49.1 million last year.

The news came after the stock dropped over 6% on Monday, amid reports investors are questioning whether Web companies can keep up revenue expansion, as some show signs of slowing gains in the number of users.

Meanwhile, the pharmaceutical sector was likely to remain in the spotlight, as Pfizer (NYSE:PFE) was said to be considering reducing its tax bill by moving its legal address outside the U.S. The drugmaker had made headlines last week after confirming its willingness to acquire London-based Astrazeneca (AZN.LONDON) for about £58.8 billion.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Separately, Herbalife (NYSE:HLF), down 0.70% in extended trade, posted higher-than-estimated earnings and increased its forecast late Monday.

Other stocks likely to be in focus included Merck & Company (NYSE:MRK), Bristol-Myers Squibb (NYSE:BMY), Twitter (NYSE:TWTR), eBay (NASDAQ:EBAY), Dreamworks Animation (NASDAQ:DWA), Forest Laboratories (NYSE:FRX) and 3D Systems (NYSE:DDD), scheduled to report quarterly results later in the day.

Across the Atlantic, European stock markets were higher. The DJ Euro Stoxx 50 gained 0.54%, France’s CAC 40 inched up 0.04%, Germany's DAX climbed 0.63%, while Britain's FTSE 100 advanced 0.54%.

During the Asian trading session, Hong Kong's Hang Seng jumped 1.45%, while Japan’s Nikkei 225 remained closed for a national holiday.

Later in the day, the U.S. was to publish a report compiled by the Conference Board on consumer confidence.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.